Dae Han New Pharm Co., Ltd. operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Dae Han New Pharm Co., Ltd. with three other
companies in this sector in KOREA (SOUTH) :
Hyundai Pharmaceutical Company Limited
sales of 134.92 billion Korean Won [US$119.14 million]
of which 81%
Reyon Pharmaceutical Co Ltd
(131.56 billion Korean Won [US$116.17 million]
of which 33%
was other finished goods), and
Theragen Etex Co Limited
(138.08 billion Korean Won [US$121.93 million]
of which 86%
was Pharmaceutical Business Segment).
Dae Han New Pharm Co., Ltd. reported sales of 134.10 billion Korean Won (US$118.41 million)
December of 2019.
increase of 12.2%
versus 2018, when the company's sales were 119.53 billion Korean Won .
Sales of Merchandise saw an increase
that was more than double the company's growth rate: sales were up
41.5% in 2019, from
18.26 billion Korean Won to 25.85 billion Korean Won .